Q2043 Sipuleucel-t auto cd54+
Q-Codes
Also known as: Provenge, sipuleucel-T, autologous cell therapy
Sipuleucel-T autologous CD54+ T-cell antigen presenting cell therapy for castration-resistant prostate cancer.
Clinical Context
Personalized vaccine therapy for asymptomatic or minimally symptomatic castration-resistant prostate cancer. Requires apheresis collection and ex vivo cell processing.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.